Literature DB >> 23459399

Coronary artery disease: to cath or not to cath? When and how best to cath: those are the remaining questions.

Roberta Rossini1, Giuseppe Musumeci, Eliano Pio Navarese, Giuseppe Tarantini.   

Abstract

Coronary artery disease is the leading cause of death worldwide and it often clinically manifests as stable angina. The optimal diagnostic and therapeutic strategy of patients with stable angina may be controversial. Coronary revascularization with percutaneous coronary intervention (PCI) is associated with a reduction in cardiovascular events in patients with acute coronary syndrome, whereas recent trials have failed to demonstrate the superiority of myocardial revascularization over optimal medical therapy in stable angina. The treatment of a patient with stable angina is still challenging, as the definition of "stable" and "unstable" is not so clear. Moreover, the benefit of PCI in terms of quality of life is evident, and independent from its neutral effect on survival. To date, the best timing of coronary angiography and the role of further investigations on myocardial ischemia still need to be defined. On the other hand, in spite of the clear benefit on clinical outcome of an early invasive treatment of patients with acute coronary syndrome, elderly are often undertreated, whereas the overtreatment with PCI of stable patients undergoing non cardiac surgery might even increase ischemic events due to the premature discontinuation of the antiplatelet therapy, without reducing the perioperative risk.

Entities:  

Keywords:  Coronary artery disease; antiplatelet therapy; coronary revascularization; diagnostic and therapeutic strategy; percutaneous coronary intervention (PCI); stable angina

Year:  2013        PMID: 23459399      PMCID: PMC3584648     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  72 in total

Review 1.  Effects of age on long-term outcomes after a routine invasive or selective invasive strategy in patients presenting with non-ST segment elevation acute coronary syndromes: a collaborative analysis of individual data from the FRISC II - ICTUS - RITA-3 (FIR) trials.

Authors:  Peter Damman; Tim Clayton; Lars Wallentin; Bo Lagerqvist; Keith A A Fox; Alexander Hirsch; Fons Windhausen; Eva Swahn; Stuart J Pocock; Jan G P Tijssen; Robbert J de Winter
Journal:  Heart       Date:  2011-09-19       Impact factor: 5.994

2.  Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.

Authors:  Duminda N Wijeysundera; Harindra C Wijeysundera; Lingsong Yun; Marcin Wąsowicz; W Scott Beattie; James L Velianou; Dennis T Ko
Journal:  Circulation       Date:  2012-08-14       Impact factor: 29.690

Review 3.  Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.

Authors:  Seema Pursnani; Frederick Korley; Ravindra Gopaul; Pushkar Kanade; Newry Chandra; Richard E Shaw; Sripal Bangalore
Journal:  Circ Cardiovasc Interv       Date:  2012-08-07       Impact factor: 6.546

4.  Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.

Authors:  Stefano Savonitto; Claudio Cavallini; A Sonia Petronio; Ernesto Murena; Roberto Antonicelli; Alice Sacco; Giuseppe Steffenino; Francesco Bonechi; Ernesto Mossuti; Antonio Manari; Salvatore Tolaro; Anna Toso; Alessandro Daniotti; Federico Piscione; Nuccia Morici; Bruno M Cesana; M Cristina Jori; Stefano De Servi
Journal:  JACC Cardiovasc Interv       Date:  2012-09       Impact factor: 11.195

5.  Age and outcome after acute coronary syndromes without persistent ST-segment elevation.

Authors:  D Hasdai; D R Holmes; D A Criger; E J Topol; R M Califf; R A Harrington
Journal:  Am Heart J       Date:  2000-05       Impact factor: 4.749

6.  Five-year follow-op of the medicine, angioplasty, or surgery study (MASS): A prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis.

Authors:  W A Hueb; P R Soares; S Almeida De Oliveira; S Ariê; R H Cardoso; D B Wajsbrot; L A Cesar; A D Jatene; J A Ramires
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

7.  [Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation].

Authors:  Roberta Rossini; Ezio Bramucci; Battistina Castiglioni; Stefano De Servi; Corrado Lettieri; Maddalena Lettino; Giuseppe Musumeci; Luigi Oltrona Visconti; Emanuela Piccaluga; Stefano Savonitto; Daniela Trabattoni; Francesca Buffoli; Dominick J Angiolillo; Francesco Bovenzi; Alberto Cremonesi; Marino Scherillo; Giulio Guagliumi
Journal:  G Ital Cardiol (Rome)       Date:  2012 Jul-Aug

8.  Catastrophic outcomes of noncardiac surgery soon after coronary stenting.

Authors:  G L Kałuza; J Joseph; J R Lee; M E Raizner; A E Raizner
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

Review 9.  Mechanisms of hypercoagulability.

Authors:  O E Dahl
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

10.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

View more
  1 in total

1.  ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy.

Authors:  Carmine Riccio; Michele Massimo Gulizia; Furio Colivicchi; Andrea Di Lenarda; Giuseppe Musumeci; Pompilio Massimo Faggiano; Maurizio Giuseppe Abrignani; Roberta Rossini; Francesco Fattirolli; Serafina Valente; Gian Francesco Mureddu; Pier Luigi Temporelli; Zoran Olivari; Antonio Francesco Amico; Giancarlo Casolo; Claudio Fresco; Alberto Menozzi; Federico Nardi
Journal:  Eur Heart J Suppl       Date:  2017-05-02       Impact factor: 1.803

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.